The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials-Reference-Cited by-同舟云学术

The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials

Published:2017-05 Issue: Volume:235 Page:73-86
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Wang Wei,Liu Jing,Fang Jingxue,Liu Yang,An Tong,Zou Meijuan,Cheng Gang

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Heart disease and stroke statistics—2016 update: a report from the American Heart Association;Writing Group M;Circulation,2016

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N. Engl. J. Med.,2003

3. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N. Engl. J. Med.,2004

4. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents;Pfisterer;J. Am. Coll. Cardiol.,2006

5. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study;Daemen;Lancet,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents;Frontiers in Cardiovascular Medicine;2022-10-19

2. Short‐term vs long‐term dual antiplatelet therapy after drug‐eluting stent implantation in patients undergoing percutaneous coronary intervention: A systematic review and meta‐analysis;International Journal of Clinical Practice;2021-01-03

3. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome;AIDS;2020-01-01

4. Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review;Canadian Journal of Cardiology;2019-08

5. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis;BMJ;2019-06-28